The invention relates to substituted aromatic polycyclic tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases.
本发明涉及可用作
胆固醇酯转移蛋白(CETP;血浆脂质转移蛋白-I)
抑制剂的取代芳香族多环叔异烷基胺化合物,以及用于治疗动脉粥样硬化和其他
冠状动脉疾病的化合物、组合物和方法。